EP4165039A4 - Monobactam-verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel - Google Patents

Monobactam-verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel Download PDF

Info

Publication number
EP4165039A4
EP4165039A4 EP20945703.5A EP20945703A EP4165039A4 EP 4165039 A4 EP4165039 A4 EP 4165039A4 EP 20945703 A EP20945703 A EP 20945703A EP 4165039 A4 EP4165039 A4 EP 4165039A4
Authority
EP
European Patent Office
Prior art keywords
preparation
antibacterial agents
monobactam compounds
novel
novel monobactam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20945703.5A
Other languages
English (en)
French (fr)
Other versions
EP4165039A1 (de
EP4165039C0 (de
EP4165039B1 (de
Inventor
Zhixiang Yang
Haikang YANG
Jinbo JI
Lijuan ZHAI
Lili He
Jian Sun
Koko MYO
Dong TANG
Yuanyu GAO
Yuanbai LIU
Yangxiu MU
Jingwen JI
Zafar Iqbal
Zawmin THU
Rui JIANG
Xueqin Ma
Jianqiang Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningxia Academy of Agriculture and Forestry Sciences
Original Assignee
Ningxia Academy of Agriculture and Forestry Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningxia Academy of Agriculture and Forestry Sciences filed Critical Ningxia Academy of Agriculture and Forestry Sciences
Publication of EP4165039A1 publication Critical patent/EP4165039A1/de
Publication of EP4165039A4 publication Critical patent/EP4165039A4/de
Application granted granted Critical
Publication of EP4165039C0 publication Critical patent/EP4165039C0/de
Publication of EP4165039B1 publication Critical patent/EP4165039B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP20945703.5A 2020-07-16 2020-07-16 Monobactam-verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel Active EP4165039B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2020/102265 WO2022011626A1 (en) 2020-07-16 2020-07-16 Novel monobactam compounds, their preparation and use as antibacterial agents

Publications (4)

Publication Number Publication Date
EP4165039A1 EP4165039A1 (de) 2023-04-19
EP4165039A4 true EP4165039A4 (de) 2023-06-21
EP4165039C0 EP4165039C0 (de) 2024-08-21
EP4165039B1 EP4165039B1 (de) 2024-08-21

Family

ID=79555997

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20945703.5A Active EP4165039B1 (de) 2020-07-16 2020-07-16 Monobactam-verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel

Country Status (4)

Country Link
US (1) US20230295149A1 (de)
EP (1) EP4165039B1 (de)
CN (1) CN115210231B (de)
WO (1) WO2022011626A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL312841A (en) * 2021-11-18 2024-07-01 Merck Sharp & Dohme Llc CHROMANE AMIDINE MONOBACTAM ANTIBIOTICS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013110643A1 (en) * 2012-01-24 2013-08-01 Aicuris Gmbh & Co. Kg Amidine substituted beta - lactam compounds, their preparation and use as antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24441B1 (es) * 2014-03-24 2019-09-04 Novartis Ag Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas
EP3541364A1 (de) * 2016-11-18 2019-09-25 AiCuris Anti-infective Cures GmbH Neuartige formulierungen von amidinsubstituierten beta-lactam-verbindungen auf basis von modifizierten cyclodextrinen und ansäuerungsmitteln, deren herstellung und verwendung als antimikrobielle pharmazeutische zusammensetzungen
CA3047634A1 (en) * 2016-12-21 2018-04-12 Aicuris Gmbh & Co. Kg Combination therapy with amidine substituted .beta.-lactam compounds and .beta.-lactamase inhibitors for infections with antibiotic resistant bacterial strains
WO2019020810A1 (en) * 2017-07-28 2019-01-31 Aicuris Anti-Infective Cures Gmbh CRYSTALLINE FORM OF (2S) -2 - [[(Z) - [- 1- (2-AMINO-4-THIAZOLYL) -2 - [[(3S) -2,2-DIMETHYL-4-OXO] -Acid 1- (SULFOOXY) -3-AZETIDINYL] AMINO] -2-OXOETHYLIDENE] AMINO] OXY] -3- [4- [IMINO [(3R) -3-PIPERIDINYLAMINO] METHYL] PHENOXY] -PROPANOIC

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013110643A1 (en) * 2012-01-24 2013-08-01 Aicuris Gmbh & Co. Kg Amidine substituted beta - lactam compounds, their preparation and use as antibacterial agents

Also Published As

Publication number Publication date
EP4165039A1 (de) 2023-04-19
EP4165039C0 (de) 2024-08-21
CN115210231A (zh) 2022-10-18
EP4165039B1 (de) 2024-08-21
WO2022011626A1 (en) 2022-01-20
CN115210231B (zh) 2024-10-08
US20230295149A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
PH12014501671B1 (en) Amidine substituted beta-lactam compounds, their preparation and use as antibacterial agents
WO2011163610A3 (en) Antimicrobial agents
EP4007759A4 (de) Beta-lactamverbindungen, ihre herstellung und verwendung als antibakterielle mittel
EP4013898A4 (de) Bakterienstämme mit fungizider wirkung, zusammensetzungen damit und deren verwendung
WO2007001335A3 (en) Ramoplanin derivatives possessing antibacterial activity
CL2014001154A1 (es) Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana.
EP3888465A4 (de) Antibakterielle zusammensetzung
EP3993628A4 (de) Antimikrobielle zusammensetzung
EP4223759A4 (de) Pyrazolopyridazinonverbindung sowie pharmazeutische zusammensetzung und verwendung davon
EP3935037A4 (de) Verwendung von 8,9-dihydrocannabidiol-verbindungen
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
MX2019014449A (es) Composiciones antimicrobianas con bajo contenido de alcohol y que se pueden esterilizar y usos de estas.
EP3977855A4 (de) Stabile mikrobizide zusammensetzung
EP3845538A4 (de) Dihydroimidazopyrazinonverbindung, zusammensetzungen damit und verwendungen davon
EP4165039A4 (de) Monobactam-verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
WO2010065110A3 (en) Antimicrobials
WO2012054521A8 (en) Antimicrobial polyether and polyol compounds
EP3957367A4 (de) Antibakterielle zusammensetzung gegen medikamentenresistente bakterien oder proinflammatorische bakterien
EP3927711A4 (de) Zusammensetzungen mit verbesserter antibakterieller wirkung gegen gram-positive bakterien und deren verwendung
EP3914587A4 (de) Oxazolidinonverbindungen und verwendungen davon als antibakterielle mittel
EP3565613A4 (de) Antimikrobielle zusammensetzungen mit antimikrobiellen hydrogelen, die gegen reife biofilme wirksam sind
AU2022300316A1 (en) Novel compounds and their use
EP3997073A4 (de) Verbindungen und verfahren zu deren verwendung als antibakterielle mittel
EP4176882A4 (de) Wässrige zusammensetzung
WO2009080788A3 (en) Antibacterial agents

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref document number: 602020036472

Country of ref document: DE

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C07D0417120000

Ipc: C07D0417140000

A4 Supplementary search report drawn up and despatched

Effective date: 20230519

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/433 20060101ALI20230512BHEP

Ipc: A61P 31/04 20060101ALI20230512BHEP

Ipc: A61K 31/427 20060101ALI20230512BHEP

Ipc: C07D 417/14 20060101AFI20230512BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240125

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240425

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602020036472

Country of ref document: DE

U01 Request for unitary effect filed

Effective date: 20240821

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20240828